Source: Fox News
Summary
Food and Drug Administration (FDA) Commissioner Marty Makary resigned on Tuesday, according to a White House official. The official stated that Makary’s resignation is due to “process at the FDA” and not a specific issue. Health and Human Services Secretary Robert F. Kennedy Jr. had pushed for Makary’s resignation. Makary’s tenure was marked by controversy over abortion drug mifepristone and vaccine policy. Kyle Diamantis, FDA deputy commissioner for Food, will serve as acting commissioner.
Our Reading
As expected, the matter has reached another stage.
Marty Makary’s resignation comes after mounting pressure from pro-life advocates and administration critics. His handling of high-profile FDA decisions and claims of slow-rolling MAHA initiatives had frustrated many. The resignation follows a series of high-profile departures this year, including former Homeland Security Secretary Kristi Noem and former Attorney General Pam Bondi. The FDA’s decisions on abortion drug mifepristone and vaccine policy had put Makary at the center of controversy. Makary’s exit is seen as a response to the growing pressure from pro-life groups and administration critics.
The process has become a familiar routine: a controversy, mounting pressure, and eventually, a resignation.
Author: Evan Null
